| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 2017-2025, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Tsang, E Cesarman, A Chadburn, YF Liu and DM Knowles
Department of Patholoy, Columbia University College of Physicians and Surgeons, New York, USA.
Primary mediastinal B cell lymphoma (PMBL) is a diffuse large B cell lymphoma (DLCL) postulated to arise from noncirculating thymic B lymphocytes. Because of its distinctive clinical and morphological features and putative unique cellular origin, PMBL is generally considered a distinct clinicopathological entity. Little is known, however, about the molecular characteristics of PMBL. Therefore, we analyzed 16 PMBLs for molecular alterations involving the bcl-1, bcl-2, bcl-6, c-myc, H-ras, K-ras, N-ras, and p53 genes and for Epstein-Barr virus infection, which are commonly involved in lymphoid neoplasia. Employing a combination of Southern blotting and/or polymerase chain reaction and single-strand conformation polymorphism assays, we detected genetic alterations in 7 of the 16 (44%) PMBLs. Whereas the bcl-6 gene is rearranged in up to 45% of DLCLs, rearrangement of the bcl-6 gene was detected in only 1 of these 16 (6%) PMBLS. Point mutations of the 5' noncoding region of the c-myc gene were demonstrated in 3 other cases (19%), although c-myc gene rearrangements were not seen by Southern blotting. Missense point mutations of the p53 gene were identified in 3 additional PMBLs (19%). Alterations of the bcl-1, bcl-2, or ras genes and evidence of Epstein-Barr virus infection were not observed. In conclusion, a variety of molecular lesions occur in PMBLs and may be involved in their pathogenesis. This molecular genetic pattern bears little resemblance to that known for other B cell malignancies, including DLCL. In particular, the infrequent occurrence of bcl-6 gene rearrangement in PMBLs distinguishes them from other DLCLs of B cell origin, suggesting that PMBLs do not represent a distinct subtype of DLCL.
This article has been cited by other articles:
 |
|
 |
|
  R. A. Roberts, G. Wright, A. R. Rosenwald, M. A. Jaramillo, T. M. Grogan, T. P. Miller, Y. Frutiger, W. C. Chan, R. D. Gascoyne, G. Ott, et al. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival Blood, July 1, 2006; 108(1): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Lossos Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma J. Clin. Oncol., September 10, 2005; 23(26): 6351 - 6357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Shipp, S. L. Aquino, and N. L. Harris Case 12-2005 - A 30-Year-Old Woman with a Mediastinal Mass N. Engl. J. Med., April 21, 2005; 352(16): 1697 - 1704. [Full Text] [PDF]
|
|
|
|
|
|
K. J. Savage, S. Monti, J. L. Kutok, G. Cattoretti, D. Neuberg, L. de Leval, P. Kurtin, P. D. Cin, C. Ladd, F. Feuerhake, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma Blood, December 1, 2003; 102(12): 3871 - 3879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Copie-Bergman, M.-L. Boulland, C. Dehoulle, P. Moller, J.-P. Farcet, M. J. S. Dyer, C. Haioun, P.-H. Romeo, P. Gaulard, and K. Leroy Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma Blood, April 1, 2003; 101(7): 2756 - 2761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris Cell cycle deregulation in B-cell lymphomas Blood, February 15, 2003; 101(4): 1220 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Pileri, G. Gaidano, P. L. Zinzani, B. Falini, P. Gaulard, E. Zucca, F. Pieri, E. Berra, E. Sabattini, S. Ascani, et al. Primary Mediastinal B-Cell Lymphoma: High Frequency of BCL-6 Mutations and Consistent Expression of the Transcription Factors OCT-2, BOB.1, and PU.1 in the Absence of Immunoglobulins Am. J. Pathol., January 1, 2003; 162(1): 243 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Leithauser, M. Bauerle, M. Q. Huynh, and P. Moller Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma Blood, November 1, 2001; 98(9): 2762 - 2770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. van Besien, M. Kelta, and P. Bahaguna Primary Mediastinal B-Cell Lymphoma: A Review of Pathology and Management J. Clin. Oncol., March 15, 2001; 19(6): 1855 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Capello, U. Vitolo, L. Pasqualucci, S. Quattrone, G. Migliaretti, L. Fassone, C. Ariatti, D. Vivenza, A. Gloghini, C. Pastore, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia Blood, January 15, 2000; 95(2): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Copie-Bergman, P. Gaulard, L. Maouche-Chretien, J. Briere, C. Haioun, M. A. Alonso, P.-H. Romeo, and K. Leroy The MAL Gene Is Expressed in Primary Mediastinal Large B-Cell Lymphoma Blood, November 15, 1999; 94(10): 3567 - 3575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Bishop, W. H. Wilson, D. Pearson, J. Janik, E. S. Jaffe, and P. C. Elwood CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma J. Clin. Oncol., August 1, 1999; 17(8): 2479 - 2479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Abou-Elella, D. D. Weisenburger, J. M. Vose, J. P. Kollath, J. C. Lynch, M. A. Bast, P. J. Bierman, T. C. Greiner, W. C. Chan, and J. O. Armitage Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group J. Clin. Oncol., March 1, 1999; 17(3): 784 - 784. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
